Balan Biosciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.50 M
as on 03-12-2024
- Company Age 18 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2022)
- Profit 3.36%
(FY 2022)
- Ebitda 22.35%
(FY 2022)
- Net Worth -0.06%
(FY 2022)
- Total Assets -0.01%
(FY 2022)
About Balan Biosciences
The Corporate was formerly known as Balan Bioscience Pvt Ltd. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Usha Nandakumar and Balakrishnan Kumar serve as directors at the Company.
- CIN/LLPIN
U73100AP2006PTC048896
- Company No.
048896
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Jan 2006
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- LocationBalan Bioscience Pvt Ltd, Andhra Pradesh
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Balan Biosciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Balakrishnan Kumar  | Director | 27-Sep-2012 | Current |
| Usha Nandakumar | Director | 25-Jan-2006 | Current |
Financial Performance and Corporate Structure Insights of Balan Biosciences.
Balan Biosciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 3.36% increase in profit. The company's net worth dipped by a decrease of 0.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Balan Biosciences?
In 2020, Balan Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Balan Property Holdings Private LimitedActive 24 years 6 monthsUsha Nandakumar and Balakrishnan Kumar are mutual person
- Balan Agro Products Private LimitedActive 12 years 8 months
Usha Nandakumar and Balakrishnan Kumar are mutual person
- Balan Organic Chemicals Private LimitedActive 3 years 8 months
Usha Nandakumar and Balakrishnan Kumar are mutual person
- Subramanya Info Tech India Private LimitedActive 7 years 4 months
Usha Nandakumar and Balakrishnan Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Balan Biosciences?
Unlock and access historical data on people associated with Balan Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Balan Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Balan Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
